Store besparelser
Hurtig levering
Gemte
Log ind
0
Kurv
Kurv

The LDN Book, Volume Two

- The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More
Af: Linda Elsegood Engelsk Paperback

The LDN Book, Volume Two

- The Latest Research on How Low Dose Naltrexone Could Revolutionize Treatment for PTSD, Pain, IBD, Lyme Disease, Dermatologic Conditions, and More
Af: Linda Elsegood Engelsk Paperback
Tjek vores konkurrenters priser

A comprehensive examination of Low Dose Naltrexone – a little-known drug with big potential

New drug [LDN] raises hopes of reversing memory loss in old age the Guardian

A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination.

Expanding on the information presented in The LDN Book, Volume 1 – which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue – Volume 2 highlights the latest clinical trials, case studies and research on LDN. More than a dozen medical professionals explain how they are using LDN to help patients suffering from:

  • Chronic pain
  • Parkinson’s disease
  • Dermatologic conditions
  • Traumatic brain injury 
  • Lyme disease and more.

Volume 1 and Volume 2 have been edited by Linda Elsegood, founder of the UK-based LDN Research Trust. Through the Trust and her work on the LDN books, Linda has connected thousands of patients, doctors and pharmacists around the world with information, articles and patient stories about LDN. The LDN Book, Volume 2 is a fantastic resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this beneficial drug.

Tjek vores konkurrenters priser
Normalpris
kr 264
Fragt: 39 kr
6 - 8 hverdage
20 kr
Pakkegebyr
God 4 anmeldelser på
Tjek vores konkurrenters priser

A comprehensive examination of Low Dose Naltrexone – a little-known drug with big potential

New drug [LDN] raises hopes of reversing memory loss in old age the Guardian

A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination.

Expanding on the information presented in The LDN Book, Volume 1 – which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue – Volume 2 highlights the latest clinical trials, case studies and research on LDN. More than a dozen medical professionals explain how they are using LDN to help patients suffering from:

  • Chronic pain
  • Parkinson’s disease
  • Dermatologic conditions
  • Traumatic brain injury 
  • Lyme disease and more.

Volume 1 and Volume 2 have been edited by Linda Elsegood, founder of the UK-based LDN Research Trust. Through the Trust and her work on the LDN books, Linda has connected thousands of patients, doctors and pharmacists around the world with information, articles and patient stories about LDN. The LDN Book, Volume 2 is a fantastic resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this beneficial drug.

Produktdetaljer
Sprog: Engelsk
Sider: 288
ISBN-13: 9781603589901
Indbinding: Paperback
Udgave:
ISBN-10: 1603589902
Udg. Dato: 24 sep 2020
Længde: 44mm
Bredde: 228mm
Højde: 154mm
Forlag: Chelsea Green Publishing Co
Oplagsdato: 24 sep 2020
Forfatter(e): Linda Elsegood
Forfatter(e) Linda Elsegood


Kategori Håndtering af sygdom og diagnoser


ISBN-13 9781603589901


Sprog Engelsk


Indbinding Paperback


Sider 288


Udgave


Længde 44mm


Bredde 228mm


Højde 154mm


Udg. Dato 24 sep 2020


Oplagsdato 24 sep 2020


Forlag Chelsea Green Publishing Co

Vi anbefaler også
Kategori sammenhænge